search
Back to results

"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

Primary Purpose

Barrett's Esophagus

Status
Terminated
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Chromoendoscopy using Acetic Acid 2.5%
Standard random esophageal biopsies
Sponsored by
DHR Health Institute for Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Barrett's Esophagus focused on measuring Barrett's Esophagus, Acetic Acid Chromoendoscopy

Eligibility Criteria

40 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients 18 years and older
  • Previous diagnosis of Barrett's esophagus, confirmed by pathology.

Exclusion Criteria:

  • Patients diagnosed with any level of dysplasia on previous esophageal biopsies.
  • Patients who had esophageal therapy with Halo radiofrequency ablation in the past, or esophagectomy.
  • History of allergy to Acetic Acid
  • History of esophageal dysplasia or cancer
  • Esophageal ulcerations
  • Esophageal Candida
  • Esophageal Varices
  • Patients with active esophagitis
  • Patients who cannot provide a valid consent
  • Patients who are currently pregnant

Sites / Locations

  • Doctors Hospital at Renaissance/Endoscopy Department

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Chromoendoscopy using Acetic Acid 2.5%

Standard random esophageal biopsies

Arm Description

Patient will have endoscopic examination of esophagus. Esophageal mucosa sprayed with 5cc solution of Acetic Acid 2.5% one time only. Esophageal mucosa examined again. Biopsies are obtained. Abnormal areas identified by Acetic Acid 2.5% will be submitted on separate containers for pathology review. If no abnormalities seen, random biopsies taken as per standard recommendations for Barrett's esophagus. Samples submitted for pathology review.

Patient will have endoscopic examination of the esophagus. Esophageal mucosa will not be sprayed with Acetic Acid 2.5%. Random biopsies taken as per standard recommendations for Barrett's esophagus. Samples submitted for pathology review.

Outcomes

Primary Outcome Measures

Total Number of Subjects With Neoplasia When Using Acetic Acid Chromoendoscopy Versus Standardized Random Biopsies.
Spray of Acetic Acid into the esophageal mucosa during routine esophageal biopsies for Barrett's esophagus surveillance increases the yield of neoplasia.

Secondary Outcome Measures

Full Information

First Posted
July 30, 2015
Last Updated
August 25, 2021
Sponsor
DHR Health Institute for Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT02614703
Brief Title
"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance
Official Title
"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance is Superior to the Standardized Random Biopsy Protocol in Detecting Neoplasia: A Prospective Randomized Study"
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Terminated
Why Stopped
Sample was under-powered
Study Start Date
March 10, 2017 (Actual)
Primary Completion Date
July 30, 2018 (Actual)
Study Completion Date
July 30, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
DHR Health Institute for Research and Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Neoplasia in Barrett's esophagus could be missed during routine random biopsies. We propose a study using chromoendoscopy with Acetic Acid to increase the yield of biopsies in detecting neoplasia.
Detailed Description
Neoplasia in Barrett's esophagus is often focal and can be missed by nontargeted biopsies alone. In recent years, various advanced endoscopic techniques have been utilized, but with varying success rates. Narrow-band imaging, trimodal imaging, spectral imaging and i-scan are technologies that are manufacturer dependent with limited varying success rates and have financial implications. At our institution, narrow band imaging is routinely utilized as a diagnostic tool for detecting Barrett's esophagus. Acetic acid is a commonly available dye that has been used in the detection of neoplasia in Barrett's esophagus. This study is aimed to prove the effectiveness of acetic acid chromoendoscopy in our Barrett's esophagus surveillance population. The goal is to compare the neoplasia yield of acetic acid chromoendoscopy with that of standardized random biopsy protocol. The sensitivity and specificity for neoplasia detection by these two methods will also be analyzed. Investigators plan to conduct this prospective randomized study for a period of one and a half years (beginning August 1, 2015, ending February 29, 2016). Based on data from 2014, we anticipate to enroll approximately 185 patients. All gastroenterologists (with privileges at Doctors Hospital at Renaissance) will participate in this study. Patients will be randomized to either acetic acid chromoendoscopy or current standard of care (standardized random biopsy protocol utilizing narrow band imaging). Random biopsies from both protocols and targeted biopsies (if identified) will be obtained and submitted to pathology department. These will be reviewed independently by two pathologists. Any discordant results will be reviewed by an outside expert pathologist. Statistical data analysis will be performed utilizing Datadesk XL software.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Barrett's Esophagus
Keywords
Barrett's Esophagus, Acetic Acid Chromoendoscopy

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Chromoendoscopy using Acetic Acid 2.5%
Arm Type
Experimental
Arm Description
Patient will have endoscopic examination of esophagus. Esophageal mucosa sprayed with 5cc solution of Acetic Acid 2.5% one time only. Esophageal mucosa examined again. Biopsies are obtained. Abnormal areas identified by Acetic Acid 2.5% will be submitted on separate containers for pathology review. If no abnormalities seen, random biopsies taken as per standard recommendations for Barrett's esophagus. Samples submitted for pathology review.
Arm Title
Standard random esophageal biopsies
Arm Type
Active Comparator
Arm Description
Patient will have endoscopic examination of the esophagus. Esophageal mucosa will not be sprayed with Acetic Acid 2.5%. Random biopsies taken as per standard recommendations for Barrett's esophagus. Samples submitted for pathology review.
Intervention Type
Drug
Intervention Name(s)
Chromoendoscopy using Acetic Acid 2.5%
Other Intervention Name(s)
chromoendoscopy using ethanoic acid 2.5%
Intervention Description
Spraying esophageal mucosa during random biopsies for Barrett's esophagus
Intervention Type
Other
Intervention Name(s)
Standard random esophageal biopsies
Intervention Description
Random esophageal biopsies performed as per protocol
Primary Outcome Measure Information:
Title
Total Number of Subjects With Neoplasia When Using Acetic Acid Chromoendoscopy Versus Standardized Random Biopsies.
Description
Spray of Acetic Acid into the esophageal mucosa during routine esophageal biopsies for Barrett's esophagus surveillance increases the yield of neoplasia.
Time Frame
142 seconds

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients 18 years and older Previous diagnosis of Barrett's esophagus, confirmed by pathology. Exclusion Criteria: Patients diagnosed with any level of dysplasia on previous esophageal biopsies. Patients who had esophageal therapy with Halo radiofrequency ablation in the past, or esophagectomy. History of allergy to Acetic Acid History of esophageal dysplasia or cancer Esophageal ulcerations Esophageal Candida Esophageal Varices Patients with active esophagitis Patients who cannot provide a valid consent Patients who are currently pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ingrid M Chacon, MD
Organizational Affiliation
Doctor's Hospital at Renaissance
Official's Role
Principal Investigator
Facility Information:
Facility Name
Doctors Hospital at Renaissance/Endoscopy Department
City
Edinburg
State/Province
Texas
ZIP/Postal Code
78539
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan to make individual data available unless otherwise asked for safety reason.
Citations:
PubMed Identifier
20601133
Citation
Longcroft-Wheaton G, Duku M, Mead R, Poller D, Bhandari P. Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2010 Oct;8(10):843-7. doi: 10.1016/j.cgh.2010.06.016. Epub 2010 Jun 30.
Results Reference
background
PubMed Identifier
24713305
Citation
Tholoor S, Bhattacharyya R, Tsagkournis O, Longcroft-Wheaton G, Bhandari P. Acetic acid chromoendoscopy in Barrett's esophagus surveillance is superior to the standardized random biopsy protocol: results from a large cohort study (with video). Gastrointest Endosc. 2014 Sep;80(3):417-24. doi: 10.1016/j.gie.2014.01.041. Epub 2014 Apr 6.
Results Reference
background

Learn more about this trial

"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

We'll reach out to this number within 24 hrs